BIO.News Newsletter

As summer comes to a close, we look at two of BIO’s big priorities when Congress returns in September. We have the facts, plus more news to know before the holiday weekend. (735 words, 3 minutes, 40 seconds)We’ll take a quick break for Labor Day, and resume publication on Monday, September 8.

We look back at BIO 2025 discussions on GLP-1s, women's health, and psychedelics – and look ahead at what a new study tells us about the future of cervical cancer. (645 words, 3 minutes, 13 seconds)

HHS is pulling mRNA research funding – here's what BIO says about it, plus a look at what drives people to become patient advocates. (674 words, 3 minutes, 22 seconds)

Here's what you need to know about the U.S.-EU tariff deal’s impact on the U.S. pharmaceutical industry—plus, BIO’s work to reauthorize the SBIR/STTR programs. (801 words, 4 minutes)

A new BIO report outlines the state of early-stage funding for biotechs. Plus, during BIO 2025, legal experts unpacked IRA litigation—here’s what you should know. (761 words, 3 minutes, 48 seconds)

BIO hit the American road again, this time to Richmond, VA to meet with Virginia Bio, local entrepreneurs and patient advocates, and a company that's reshoring production of advanced pharmaceutical ingredients. Plus a look back at BIO 2025 conversations on IP and AMR. (662 words, 3 minutes, 18 seconds)

We hope you enjoyed the July break. We're back with a look at a new measles record, and what BIO's saying about the One, Big, Beautiful Bill Act, drug patents, and more. (873 words, 4 minutes, 21 seconds)

A busy week on Capitol Hill brought BIO Board member testimony and developments on issues where BIO’s advocacy remains hyper-focused, including PPRV, ORPHAN Cures, and vaccination. Plus, ACIP stirs concerns, and the BIOTech Caucus launches. (855 words, 4 minutes, 16 seconds)We'll take a break next Monday for the holiday weekend. We'll be back Monday July 14.

Today we look at why the Pediatric Priority Review Voucher needs to be reauthorized, and how global collaboration can lead us to the "biological century." (640 words, 3 minutes, 12 seconds)

That's a wrap. As we travel home from Boston, we take a look at why we do what we do – and hear from patient advocates who inspire us. Keep an eye on Bio.News for continued coverage all summer long, and catch up on the conversation on LinkedIn or your favorite social media platform with #BIO2025. (607 words, 3 minutes, 2 seconds)